In Vivo Toxicity, Redox-Modulating Capacity and Intestinal Permeability of Novel Aroylhydrazone Derivatives as Anti-Tuberculosis Agents

MLA

Violeta Valcheva, et al. “In Vivo Toxicity, Redox-Modulating Capacity and Intestinal Permeability of Novel Aroylhydrazone Derivatives as Anti-Tuberculosis Agents.” Pharmaceutics, vol. 15, no. 1, Dec. 2022, p. 79. EBSCOhost, https://doi.org/10.3390/pharmaceutics15010079.

APA

Violeta Valcheva, Rumyana Simeonova, Milka Mileva, Stanislav Philipov, Reneta Petrova, Simeon Dimitrov, Almira Georgieva, Elina Tsvetanova, Yoana Teneva, & Violina T. Angelova. (2022). In Vivo Toxicity, Redox-Modulating Capacity and Intestinal Permeability of Novel Aroylhydrazone Derivatives as Anti-Tuberculosis Agents. Pharmaceutics, 15(1), 79. https://doi.org/10.3390/pharmaceutics15010079

Chicago

Violeta Valcheva, Rumyana Simeonova, Milka Mileva, Stanislav Philipov, Reneta Petrova, Simeon Dimitrov, Almira Georgieva, Elina Tsvetanova, Yoana Teneva, and Violina T. Angelova. 2022. “In Vivo Toxicity, Redox-Modulating Capacity and Intestinal Permeability of Novel Aroylhydrazone Derivatives as Anti-Tuberculosis Agents.” Pharmaceutics 15 (1): 79. doi:10.3390/pharmaceutics15010079.